According to Research by SNS Insider, Global Prostate Cancer Diagnostics Market Growth is Fueled by Growing Demand for Advanced Biomarker Testing, AI Diagnostics, and Outpatient Screening Services ...

A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...

Artificial intelligence can help urologists and oncologists make treatment recommendations that are objective and evidence-based.

“This test could turn the tide on prostate cancer,” said Prof. Ros Eeles, who led the study. “We have shown that a relatively simple, inexpensive spit test to identify men of European heritage at ...

The West L.A. clinic enables Angelenos to take a preventative rather than reactive approach to their health by testing for ...

The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

It is well known that men are reluctant to see a doctor, especially a urologist. As a result, there is a risk that prostate ...

Discover a recent study that found that microultrasonography-guided biopsy could provide an alternative to MRI.

As per Vantage Market Research, the Global Fusion Biopsy Market has been rapidly growing due to the advancements in medical imaging technology, the increasing prevalence of prostate cancer, and the ...

In this video, Alan Dow, MD, MSHA, FACP, discusses evolving cancer screening guidelines and the controversies surrounding some of them. The first screening update involved pancreatic cancer.

An at-home saliva test that assesses genetic risk of prostate cancer may be more accurate than PSA level or MRI.

Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...